Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F.J. Geurs"'
Autor:
J. Barton, I. Hilderson, N.E. Nifantiev, Mitchell Dowsett, L.V. Fetisova, Richard S. Finn, Steve Chan, Carla Giorgetti, Maria Koehler, Steffan N. Ho, Mehrnoush Aeinfar, Roger A'Hern, M.T. Huizing, E. A. Perez, Agustin A. Garcia, M. Merrouche, G. Jerusalem, A. Ammari, C. Rejeeth, S.M. O'Reilly, Kristen J. Pierce, J. Cortes, John T. Hamm, Mehrdad Payandeh, DJ Slamon, Robert E. Coleman, Mohammad Erfan Zare, A Breazna, Robert Millham, K. Bouzid, A. Bensalem, Katalin Boér, Sinil Kim, Gary Borzillo, M.V. Kiselevskii, Roma Parikh, S. Kannan, F.J. Geurs, A Mehdi, A. Benmerzouk, M. Criel, P. Debrucker, John Crown, István Láng, O.S. Zhukova, A.M. Shcherbakov, Sophia Randolph, Ahmad Awada
Publikováno v:
Annals of Oncology. 23:ii43
Background PD 0332991, a selective inhibitor of CDK 4/6, prevents cellular DNA synthesis by blocking cell cycle progression. Preclinical studies in a BC cell line panel identified the luminal ER subtype, elevated expression of cyclin D1 and Rb protei
Publikováno v:
Annals of Oncology. 23:ii45
Background The management of metastatic breast cancer has moved to tailored treatment following the discovery of different tumor types by genotyping. Triple negative breast cancer was proven to be a chemosensitive disease where platinum salts were al
Publikováno v:
Annals of Oncology. 23:ii30
Background Predominantly retrospective analysis of primary breast cancer and the recurrences has demonstrated discordance rates of 15–40% for Er/Pgr and 7–26% for HER2 amplification, respectively. Whether this translates in therapeutic changes ha
Autor:
R. Gerhard, C. Dou, O. Brouckaert, M.L. Riis, S.Z. Derici, Janghyun Kim, V. Baksa Reynolds, M.A. Kocdor, I. Vergote, F. Haufe, H. Wildiers, K. Park, M. Rodionova, Gimun Gwak, O. Harmancioglu, F. Schmitt, H.S. Teh, S. Mukhopadhyay, B. Isgar, S. Saydam, R. Kronenwett, A. Genin, M. Criel, H. Xing, A.M. Bishr, A. Van Steen, S. Ricardo, C. Székely, D. Deme, S. Sengupta, V. Rodionov, J. Nizar, Z. Szllsi, K. Van Hoorde, A. Ismail, C. Van Ongeval, S. Wu, E. Chereau, I. Peták, T. Canda, F.J. Geurs, Y. Song, A. Raj, L. Kovács, Z. Tahmasebi Fard, S. Dasgupta, J.C. Brase, R. Rouzier, C. Richardson, K.E. Weber, T. Dou, S. Gangopadhyay, A. Telekes, Z. Xu, J. Budzies, J. Gligorov, T. Luders, A.I. Sevinc, C. Petry, Vessela N. Kristensen, P. Demetter, J.K. Kushwaha, I. Hilderson, J. Kumar, Yanliang Gu, M. Dietel, J. Paredes, A. Parvaiz, B. Jóri, B. Van Calster, P. Neven, J. Basak, T.R. Shimpi, P. Moerman, P. Hor, E. Kellen, M. Christiaens, S. Bendifallah, A.A. Sonkar, S. Han, C. Denkert, A. Schoneveld, B.M. Müller, T. Micsik, J. Prinzler, E. Van Limbergen, A. Mukhopadhyay, I.R. Bukholm, U.K. Roy, C. Truyers, E. Laas
Publikováno v:
Annals of Oncology. 23:ii27
Gene expression studies on breast cancer have generally been performed on tissue obtained at the time of surgery. Overexpression of several genes may be a result of surgical trauma or preoperative manipulation, such as the injection of radioactive su